Exploring binding mode assessment of novel kaempferol, resveratrol, and quercetin derivatives with PPAR-α as potent drug candidates against cancer

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Molecular diversity

• Publication date

  2022-12-21

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s11030-022-10587-2PMID 36544031
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Kaempferol induces ROS-dependent apoptosis in pancreatic cancer cells via TGM2-mediated Akt/mTOR signaling

  2021cited by this paper
• Kaempferol and Its Glycoside Derivatives as Modulators of Etoposide Activity in HL-60 Cells

  2021cited by this paper
• The Role of Peroxisome Proliferator-Activated Receptor in Addiction: A Novel Drug Target.

  2021cited by this paper
• Natural products and analogs as preventive agents for metabolic syndrome via peroxisome proliferator-activated receptors: An overview.

  2021cited by this paper
• In silico molecular docking studies and MM/GBSA analysis of coumarin-carbonodithioate hybrid derivatives divulge the anticancer potential against breast cancer

  2020cited by this paper
• Quercetin Attenuates Atherosclerosis via Modulating Oxidized LDL-Induced Endothelial Cellular Senescence

  2020cited by this paper
• Designing Novel Quercetin Derivatives as Matrix Metalloproteinase-9 Inhibitors in Colon Carcinoma: An In vitro and In silico Approach

  2020cited by this paper
• Quercetin and cancer: new insights into its therapeutic effects on ovarian cancer cells

  2020cited by this paper
• Pharmacophore based virtual screening, molecular docking, molecular dynamics and MM-GBSA approach for identification of prospective SARS-CoV-2 inhibitor from natural product databases

  2020cited by this paper
• Probing intermolecular interactions and binding stability of kaempferol, quercetin and resveratrol derivatives with PPAR-γ: docking, molecular dynamics and MM/GBSA approach to reveal potent PPAR- γ agonist against cancer

  2020cited by this paper
• Exploring conformational changes of PPAR-Ɣ complexed with novel kaempferol, quercetin, and resveratrol derivatives to understand binding mode assessment: a small-molecule checkmate to cancer therapy

  2020cited by this paper
• The Effects of Resveratrol in Patients with Cardiovascular Disease and Heart Failure: A Narrative Review

  2019cited by this paper
• Resveratrol inhibits the invasion and metastasis of colon cancer through reversal of epithelial- mesenchymal transition via the AKT/GSK-3β/Snail signaling pathway

  2019cited by this paper
• Kaempferol: A Key Emphasis to Its Anticancer Potential

  2019cited by this paper
• The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential

  2019cited by this paper
• Application of docking and active site analysis for enzyme linked biodegradation of textile dyes.

  2019cited by this paper
• A Review of Resveratrol as a Potent Chemoprotective and Synergistic Agent in Cancer Chemotherapy

  2019cited by this paper
• The Opportunities and Challenges of Peroxisome Proliferator-Activated Receptors Ligands in Clinical Drug Discovery and Development

  2018cited by this paper
• Identification of new drug-like compounds from millets as Xanthine oxidoreductase inhibitors for treatment of Hyperuricemia: A molecular docking and simulation study

  2018cited by this paper
• Bridging Molecular Docking to Molecular Dynamics in Exploring Ligand-Protein Recognition Process: An Overview

  2018cited by this paper
• The Flavonoid Kaempferol Ameliorates Streptozotocin-Induced Diabetes by Suppressing Hepatic Glucose Production

  2018cited by this paper
• Structural basis for differential activities of enantiomeric PPARγ agonists: Binding of S35 to the alternate site.

  2017cited by this paper
• Anticancer and apoptosis-inducing effects of quercetin in vitro and in vivo

  2017cited by this paper
• Low dose of kaempferol suppresses the migration and invasion of triple-negative breast cancer cells by downregulating the activities of RhoA and Rac1

  2017cited by this paper
• Effects of PPARα inhibition in head and neck paraganglioma cells

  2017cited by this paper
• SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules

  2017cited by this paper
• Peroxisome proliferator-activated receptor (PPAR) α and δ activators induce ICAM-1 expression in quiescent non stimulated endothelial cells

  2016cited by this paper
• Structural insights into conformational stability of both wild-type and mutant EZH2 receptor

  2016cited by this paper
• Molecular modelling studies of sirtuin 2 inhibitors using three-dimensional structure-activity relationship analysis and molecular dynamics simulations.

  2015cited by this paper
• Design of novel potential aromatase inhibitors via hybrid pharmacophore approach: docking improvement using the QM/MM method

  2015cited by this paper
• The effect of quercetin and kaempferol aglycones and glucuronides on peroxisome proliferator-activated receptor-gamma (PPAR-γ).

  2015cited by this paper
• A role for peroxisome proliferator-activated receptor gamma in resveratrol-induced colon cancer cell apoptosis.

  2014cited by this paper
• Is cancer a metabolic disease?

  2014cited by this paper
• Role of the PPAR-α agonist fenofibrate in severe pediatric burn.

  2012cited by this paper
• Plasma Rich in Quercetin Metabolites Induces G2/M Arrest by Upregulating PPAR-γ Expression in Human A549 Lung Cancer Cells

  2011cited by this paper
• PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions.

  2011cited by this paper
• Rhabdomyolysis-Induced Acute Renal Failure Following Fenofibrate Therapy: A Case Report and Literature Review

  2010cited by this paper
• Prediction of Absolute Solvation Free Energies using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field.

  2010influential reference
• Pharmacoepidemiology safety study of fibrate and statin concomitant therapy.

  2010cited by this paper
• Optimized Hydrophobic Interactions and Hydrogen Bonding at the Target-Ligand Interface Leads the Pathways of Drug-Designing

  2010cited by this paper
• PPARs: diverse regulators in energy metabolism and metabolic diseases

  2010cited by this paper
• Adaptability and selectivity of human peroxisome proliferator-activated receptor (PPAR) pan agonists revealed from crystal structures

  2009cited by this paper
• Kaempferol and quercetin isolated from Euonymus alatus improve glucose uptake of 3T3-L1 cells without adipogenesis activity.

  2008cited by this paper
• Plants as a source of anti-cancer agents.

  2005cited by this paper
• Comparative study of several algorithms for flexible ligand docking

  2003influential reference
• The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure

  1994cited by this paper
• Comparison of simple potential functions for simulating liquid water

  1983cited by this paper

• Resveratrol for Cancer Treatment: Effects on Metabolism and Immune Cells

  2026cites this paper
• Current State of Knowledge of the Anticancer Properties of Polyphenolic Compounds from Garlic (Allium sativum L.)

  2026cites this paper
• Kaempferol Regulates Lipid Homeostasis, Endocannabinoid System, and PPARα in Rat Cerebral Cortex Following BCCAO/R

  2025cites this paper
• Uncovering the Tumorigenic Blueprint of PFOS and PFOA Through Multi-Organ Transcriptomic Analysis of Biomarkers, Mechanisms, and Therapeutic Targets

  2025cites this paper
• Pseudolaric Acid B Alleviates Non-alcoholic Fatty Liver Disease by Targeting PPARα to Regulate Lipid Metabolism and Promote Mitochondrial Biogenesis

  2025cites this paper
• Exserolide J ameliorates lipid accumulation in vitro by regulating liver X receptor alpha and peroxisome proliferator-activated receptor alpha proteins

  2024cites this paper
• Dietary flavonoids as modulators of non-coding RNAs in hormone-associated cancer

  2023cites this paper